Truveris, a health IT analytics business that seeks to help employers, labor unions, and consumers reduce what they pay for prescription drugs, has closed a $25 million Series D round, according to a news release. The company will use the funding partly to boost staff by 20 percent by the end of the year, according to Jeff Ignaszak, Chief Marketing Officer at Truveris, who emailed responses to questions regarding the fundraise.
McKesson Ventures led the Series D, but Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, and New Atlantic Ventures also took part in the round. So far, Truveris has raised $62 million.
How to Optimize Your Phlebotomy Setup for Efficient Patient Care
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
Most of the new hires the company expects to make will be in sales, marketing and account management.
The company’s flagship app, OneRx, is aimed at the consumer market and is used to compare prices for branded drugs with generics and to see pricing with and without insurance.
Truveris used its cloud-based data analytics platform to create an online market where pharmacy benefit managers compete for business, said Ignaszak.
Ignaszak noted that it also works with employers and labor unions seeking to not only cut costs but also track the performance of their pharmacy benefits plans. He credited the company’s technology with helping the State of New Jersey save $1.6 billion in prescription drug spend over a three-year period.
Navigating The Right Steps For Your Healthcare Startup
This webinar will explore how a banking platform approach could be the resource for your company.
Truveris also works with pharma companies to design, execute and monitor patient access strategies to improve prescription fill rates and medication adherence.
Photo: gerenme, Getty Images